About AZUREJAYBIO INC
AllerGene AI Therapeutics is a biotechnology company focused on developing cell and gene therapy solutions for severe allergies, mast cell diseases, and anaphylaxis using in vivo-delivered mRNA CAR-T cells. The company aims to reset the immune system safely without permanent alteration.
Development of in vivo-delivered mRNA CAR-T cell therapiesTargeting mast cells to treat severe allergic reactionsExpertise in cell and gene therapyCollaboration with leading institutions and experts in immunology and oncology
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AZUREJAYBIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.